Intelligent Bio Solutions...

NASDAQ: INBS · Real-Time Price · USD
1.48
-0.03 (-1.99%)
At close: Aug 14, 2025, 3:59 PM
1.45
-1.69%
Pre-market: Aug 15, 2025, 07:04 AM EDT

Intelligent Bio Solutions Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
3.11M 1.26M n/a 1.98M
Cost of Revenue
1.69M 930.2K n/a n/a
Gross Profit
1.43M 326.67K n/a 1.98M
Operating Income
-10.28M -12.6M -8.34M -5.57M
Interest Income
84.82K 9.68K 14.43K 13.81K
Pretax Income
-10.19M -10.63M -8.33M -8.52M
Net Income
-10.16M -10.63M -8.31M -7.04M
Selling & General & Admin
9.26M 8.03M 4.92M 3.71M
Research & Development
1.67M 507.42K 3.85M 3.84M
Other Expenses
776.5K 4.39M -437K n/a
Operating Expenses
11.71M 8.53M 8.34M 7.2M
Interest Expense
167.14K 223.53K 7.54K 1.09M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
13.39M 9.69M 8.34M 7.55M
Income Tax Expense
n/a 190.7K -27.93K 2.5M
Shares Outstanding (Basic)
3.19M 2.01M 733.26K 520.74K
Shares Outstanding (Diluted)
3.19M 2.01M 733.26K 520.74K
EPS (Basic)
-6.38 -10.58 -11.33 -16.22
EPS (Diluted)
-6.38 -10.58 -11.33 -16.22
EBITDA
-8.81M -9.47M 30.82K -1.82M
EBIT
-10.02M -10.44M -8.33M -5.83M
Depreciation & Amortization
1.2M 966.73K 8.34M 5.21M